Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
FDA: Mirtazapine, marketed as Remeron/RemeronSolTab, received initial U.S. approval in 1996 for treating major depressive disorder (MDD) in adults.
EMA: In the EU, mirtazapine is indicated for major depressive episodes. Initially approved in individual Member States, its product information was harmonised through an Article 30 referral, culminating in a European Commission decision on 15 September 2008.
see also:
[Antidepressant & Major depressive disorder / Major Depression / Depressive episode (MDD…